Brief: Orexo Sees 2024 Buprenorphine/Naloxone Market To Grow 2-5%

Orexo AB

08/05/2024 07:09

May 8 (Reuters) - Orexo AB  ORX.ST :
    * FINANCIAL OUTLOOK 2024: BUPRENORPHINE/NALOXONE MARKET WILL
GROW
2-5 PERCENT, BASED ON CURRENT GROWTH TRAJECTORY
    * FINANCIAL OUTLOOK 2024: COST CONTROL IS PRIORITY AND OPEX
EXCLUDING DEPRECIATION AND AMORTIZATION WILL DECLINE FROM SEK
582 M IN 2023 TO BELOW SEK 530 M IN 2024
    * FINANCIAL OUTLOOK 2024: POSITIVE EBITDA FOR FY 2024
    * FINANCIAL OUTLOOK 2024: ZUBSOLV® NET SALES IN USD WILL BE
IN
LINE WITH 2023

Source text for Eikon:  ID:nWkr7RrNS3 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))